OLIGODENDROCYTES AS A CRITICAL CELL-TYPE IN PARKINSON'S DISEASE

• Juan Manuel Barba Reyes,
• Lisbeth Harder,
• Mónica Díez Salguero,
• Leonardo Garma,
• Alberto Serrano Pozo,
• Bradley Hyman,
• Ana Muñoz Manchado

Affiliations

Juan Manuel Barba Reyes

University of Cádiz, Dep. Of Pathological Anatomy, Cell Biology, Histology, History Of Science, Forensic And Legal Medicine And Toxicology. Inibica (institute Of Biomedical And Innovative Research Of Cadiz., Cádiz, Spain

Lisbeth Harder

Karolinska Institutet, Department Of Medical Biochemistry And Biophysics, Stockholm, Sweden

Mónica Díez Salguero

University of Cádiz, Dep. Of Pathological Anatomy, Cell Biology, Histology, History Of Science, Forensic And Legal Medicine And Toxicology. Inibica (institute Of Biomedical And Innovative Research Of Cadiz., Cádiz, Spain

Leonardo Garma

Karolinska Institutet, Department Of Medical Biochemistry And Biophysics, Stockholm, Sweden

Alberto Serrano Pozo

Harvard Medical School, Department Of Neurology, Charlestown, United States of America

Bradley Hyman

Harvard Medical School, Department Of Neurology, Charlestown, United States of America

Ana Muñoz Manchado

University of Cádiz, Dep. Of Pathological Anatomy, Cell Biology, Histology, History Of Science, Forensic And Legal Medicine And Toxicology. Inibica (institute Of Biomedical And Innovative Research Of Cadiz., Cádiz, Spain; Karolinska Institutet, Department Of Medical Biochemistry And Biophysics, Stockholm, Sweden